351 related articles for article (PubMed ID: 25417702)
41. Regulation and activation of p53 and its family members.
Lohrum MA; Vousden KH
Cell Death Differ; 1999 Dec; 6(12):1162-8. PubMed ID: 10637431
[TBL] [Abstract][Full Text] [Related]
42. Inactivation of p53 signaling by p73 or PTEN ablation results in a transformed phenotype that remains susceptible to Nutlin-3 mediated apoptosis.
Cipriano R; Patton JT; Mayo LD; Jackson MW
Cell Cycle; 2010 Apr; 9(7):1373-9. PubMed ID: 20305378
[TBL] [Abstract][Full Text] [Related]
43. MDM2 antagonist can inhibit tumor growth in hepatocellular carcinoma with different types of p53 in vitro.
Wang J; Zheng T; Chen X; Song X; Meng X; Bhatta N; Pan S; Jiang H; Liu L
J Gastroenterol Hepatol; 2011 Feb; 26(2):371-7. PubMed ID: 21261729
[TBL] [Abstract][Full Text] [Related]
44. p63 and p73: roles in development and tumor formation.
Moll UM; Slade N
Mol Cancer Res; 2004 Jul; 2(7):371-86. PubMed ID: 15280445
[TBL] [Abstract][Full Text] [Related]
45. HDM2 antagonist Nutlin-3 disrupts p73-HDM2 binding and enhances p73 function.
Lau LM; Nugent JK; Zhao X; Irwin MS
Oncogene; 2008 Feb; 27(7):997-1003. PubMed ID: 17700533
[TBL] [Abstract][Full Text] [Related]
46. Expression of p53 and its homologues in primary and recurrent squamous cell carcinomas of the head and neck.
Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
Int J Cancer; 2002 May; 99(1):22-8. PubMed ID: 11948487
[TBL] [Abstract][Full Text] [Related]
47. The human MDM2 oncoprotein increases the transcriptional activity and the protein level of the p53 homolog p63.
Calabrò V; Mansueto G; Parisi T; Vivo M; Calogero RA; La Mantia G
J Biol Chem; 2002 Jan; 277(4):2674-81. PubMed ID: 11714701
[TBL] [Abstract][Full Text] [Related]
48. Effect of hydroxyurea on the promoter occupancy profiles of tumor suppressor p53 and p73.
Huang V; Lu X; Jiang Y; Wang JY
BMC Biol; 2009 Jun; 7():35. PubMed ID: 19558638
[TBL] [Abstract][Full Text] [Related]
49. p73 and MDM2 confer the resistance of epidermoid carcinoma to cisplatin by blocking p53.
Hayashi S; Ozaki T; Yoshida K; Hosoda M; Todo S; Akiyama S; Nakagawara A
Biochem Biophys Res Commun; 2006 Aug; 347(1):60-6. PubMed ID: 16815295
[TBL] [Abstract][Full Text] [Related]
50. Comparative analysis of p73 and p53 regulation and effector functions.
Fang L; Lee SW; Aaronson SA
J Cell Biol; 1999 Nov; 147(4):823-30. PubMed ID: 10562283
[TBL] [Abstract][Full Text] [Related]
51. Are interactions with p63 and p73 involved in mutant p53 gain of oncogenic function?
Li Y; Prives C
Oncogene; 2007 Apr; 26(15):2220-5. PubMed ID: 17401431
[TBL] [Abstract][Full Text] [Related]
52. Identification of a sequence element from p53 that signals for Mdm2-targeted degradation.
Gu J; Chen D; Rosenblum J; Rubin RM; Yuan ZM
Mol Cell Biol; 2000 Feb; 20(4):1243-53. PubMed ID: 10648610
[TBL] [Abstract][Full Text] [Related]
53. The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network.
Boominathan L
Cancer Metastasis Rev; 2010 Dec; 29(4):613-39. PubMed ID: 20922462
[TBL] [Abstract][Full Text] [Related]
54. A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinoma.
Ory B; Ramsey MR; Wilson C; Vadysirisack DD; Forster N; Rocco JW; Rothenberg SM; Ellisen LW
J Clin Invest; 2011 Feb; 121(2):809-20. PubMed ID: 21293058
[TBL] [Abstract][Full Text] [Related]
55. iASPP inhibits p53-independent apoptosis by inhibiting transcriptional activity of p63/p73 on promoters of proapoptotic genes.
Cai Y; Qiu S; Gao X; Gu SZ; Liu ZJ
Apoptosis; 2012 Aug; 17(8):777-83. PubMed ID: 22538442
[TBL] [Abstract][Full Text] [Related]
56. The evolution of MDM2 family genes.
Momand J; Villegas A; Belyi VA
Gene; 2011 Oct; 486(1-2):23-30. PubMed ID: 21762762
[TBL] [Abstract][Full Text] [Related]
57. Mdm2 inhibition induces apoptosis in p53 deficient human colon cancer cells by activating p73- and E2F1-mediated expression of PUMA and Siva-1.
Ray RM; Bhattacharya S; Johnson LR
Apoptosis; 2011 Jan; 16(1):35-44. PubMed ID: 20812030
[TBL] [Abstract][Full Text] [Related]
58. Design of a novel MDM2 binding peptide based on the p53 family.
Madhumalar A; Lee HJ; Brown CJ; Lane D; Verma C
Cell Cycle; 2009 Sep; 8(17):2828-36. PubMed ID: 19713735
[TBL] [Abstract][Full Text] [Related]
59. p53 Family isoforms.
Bourdon JC
Curr Pharm Biotechnol; 2007 Dec; 8(6):332-6. PubMed ID: 18289041
[TBL] [Abstract][Full Text] [Related]
60. Expression of p53 family genes in urinary bladder cancer: correlation with disease aggressiveness and recurrence.
Papadogianni D; Soulitzis N; Delakas D; Spandidos DA
Tumour Biol; 2014 Mar; 35(3):2481-9. PubMed ID: 24213852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
